DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Sean McCarthy will participate on a panel titled “Specialty Pharma Play: Are We Near the End?” at the Bio International Convention in Atlanta, GA
News | 05. 21. 2009
